Literature DB >> 21797675

Enhancement of radiosensitivity and the potential mechanism on human esophageal carcinoma cells by tetrandrine.

Jingping Yu1, Fenju Liu, Meiling Sun, Zhiqiang Sun, Suping Sun.   

Abstract

The purposes of this study were to test the effect of tetrandrine, alone or combined with radiation, on human esophageal cancer cell line TE1 (TE1 cells) and investigate the potential antitumor mechanism. Human esophageal cancer cell line TE1 was tested by methyl thiazolyl tetrazolium assay for cell proliferation, colony-forming assay for cell radiosensitivity, flow cytometry assay for cell cycle distribution, and western blot assay for cell cycle protein expression. When treated alone, tetrandrine had a time- and concentration-dependent cytotoxic effect on TE1 cells. The dose-enhancement ratio for combined tetrandrine and radiation was markedly increased when compared with tetrandrine alone. Further, expression of cyclin B1 protein increased after addition of tetrandrine when compared with radiation only. Radiation-induced G2 arrest was abrogated with treatment of tetrandrine. In conclusion, tetrandrine can enhance the radiosensitivity of TE1 cells and this may involve relief of radiation-induced G2/M arrest in TE1 cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21797675     DOI: 10.1089/cbr.2011.0964

Source DB:  PubMed          Journal:  Cancer Biother Radiopharm        ISSN: 1084-9785            Impact factor:   3.099


  7 in total

1.  Tetrandrine enhances radiosensitivity through the CDC25C/CDK1/cyclin B1 pathway in nasopharyngeal carcinoma cells.

Authors:  Jun Wang; Lihong Chang; Xiaoping Lai; Xia Li; Zhiyuan Wang; Zizhen Huang; Jiancong Huang; Gehua Zhang
Journal:  Cell Cycle       Date:  2018       Impact factor: 4.534

2.  Clinical trial of thalidomide combined with radiotherapy in patients with esophageal cancer.

Authors:  Jing-Ping Yu; Su-Ping Sun; Zhi-Qiang Sun; Xin-Chu Ni; Jian Wang; Yi Li; Li-Jun Hu; Dong-Qing Li
Journal:  World J Gastroenterol       Date:  2014-05-07       Impact factor: 5.742

3.  Alkaloids isolated from natural herbs as the anticancer agents.

Authors:  Jin-Jian Lu; Jiao-Lin Bao; Xiu-Ping Chen; Min Huang; Yi-Tao Wang
Journal:  Evid Based Complement Alternat Med       Date:  2012-09-04       Impact factor: 2.629

Review 4.  Tetrandrine, a Chinese plant-derived alkaloid, is a potential candidate for cancer chemotherapy.

Authors:  Ting Liu; Xin Liu; Wenhua Li
Journal:  Oncotarget       Date:  2016-06-28

5.  Tetrandrine Exerts a Radiosensitization Effect on Human Glioma through Inhibiting Proliferation by Attenuating ERK Phosphorylation.

Authors:  Ji-Wei Ma; Yong Zhang; Ji-Cheng Ye; Ru Li; Yu-Lin Wen; Jian-Xian Huang; Xue-Yun Zhong
Journal:  Biomol Ther (Seoul)       Date:  2017-03-01       Impact factor: 4.634

6.  Synergistic effects of tetrandrine combined with ionizing radiation on a murine colorectal carcinoma‑bearing mouse model.

Authors:  Wei-Chan Lin; Wei-Hsun Wang; Yi-Hsien Lin; Jyh-Der Leu; Shan-Yun Cheng; Yu-Jen Chen; Jeng-Jong Hwang
Journal:  Oncol Rep       Date:  2018-07-12       Impact factor: 3.906

7.  Tetrandrine sensitizes nasopharyngeal carcinoma cells to irradiation by inducing autophagy and inhibiting MEK/ERK pathway.

Authors:  Jun Wang; Zhouzhou Yao; Xiaoping Lai; Hongwei Bao; Yue Li; Shuaixiang Li; Lihong Chang; Gehua Zhang
Journal:  Cancer Med       Date:  2020-08-11       Impact factor: 4.452

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.